Journal article icon

Journal article

Imaging oligometastatic cancer before local treatment.

Abstract:

With the advent of novel treatment strategies to help widen the therapeutic window for patients with oligometastatic cancer, improved biomarkers are needed to reliably defi ne patients who can benefi t from these treatments. Multimodal imaging is one such option and should be optimised to comprehensively assess metastatic sites, disease burden, and response to neoadjuvant treatment in each disease setting. These features will probably remain important prognostic biomarkers, and are crucial in...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
More by this author
Institution:
University of Oxford
Oxford college:
St Hugh's College
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Role:
Author
More from this funder
Name:
Cancer Research UK
Grant:
8971
Publisher:
Elsevier
Journal:
Lancet Oncology More from this journal
Volume:
17
Issue:
9
Pages:
e406-e414
Publication date:
2016-08-01
DOI:
EISSN:
1474-5488
ISSN:
1470-2045
Pmid:
27599145
Language:
English
Keywords:
Pubs id:
pubs:641850
UUID:
uuid:d24df7aa-f2f5-41fa-8cbd-d60ff87048e5
Local pid:
pubs:641850
Source identifiers:
641850
Deposit date:
2017-06-14

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP